Katja Mitrunen

1.5k total citations
16 papers, 1.3k citations indexed

About

Katja Mitrunen is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Katja Mitrunen has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Genetics and 3 papers in Oncology. Recurrent topics in Katja Mitrunen's work include Glutathione Transferases and Polymorphisms (7 papers), BRCA gene mutations in cancer (5 papers) and Nutrition, Genetics, and Disease (4 papers). Katja Mitrunen is often cited by papers focused on Glutathione Transferases and Polymorphisms (7 papers), BRCA gene mutations in cancer (5 papers) and Nutrition, Genetics, and Disease (4 papers). Katja Mitrunen collaborates with scholars based in Finland, France and Switzerland. Katja Mitrunen's co-authors include Ari Hirvonen, Simone Benhamou, Matti Eskelinen, Vesa Kataja, Harri Vainio, Matti Uusitupa, Veli‐Matti Kosma, Kim Pettersson, Timo Lövgren and Pierre Dayer and has published in prestigious journals such as International Journal of Cancer, Clinical Chemistry and Carcinogenesis.

In The Last Decade

Katja Mitrunen

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katja Mitrunen Finland	14	750	466	264	193	147	16	1.3k
Nigel T. Brockton Canada	22	639 0.9×	180 0.4×	544 2.1×	277 1.4×	129 0.9×	42	1.6k
Gary Zirpoli United States	24	562 0.7×	329 0.7×	785 3.0×	355 1.8×	122 0.8×	74	1.8k
LaVerne A. Mooney United States	16	520 0.7×	137 0.3×	175 0.7×	478 2.5×	132 0.9×	29	1.3k
Robert W. Haile United States	21	895 1.2×	425 0.9×	270 1.0×	262 1.4×	78 0.5×	32	1.5k
Cathryn H. Bock United States	23	590 0.8×	245 0.5×	430 1.6×	392 2.0×	794 5.4×	57	1.7k
M. R. Spitz United States	17	1.0k 1.4×	134 0.3×	443 1.7×	589 3.1×	160 1.1×	24	1.8k
Javier G. Blanco United States	24	600 0.8×	138 0.3×	472 1.8×	157 0.8×	158 1.1×	75	1.8k
Oreste E. Salavaggione United States	16	468 0.6×	223 0.5×	282 1.1×	119 0.6×	111 0.8×	25	988
F. L. Meyskens United States	13	583 0.8×	125 0.3×	534 2.0×	126 0.7×	167 1.1×	23	1.4k
Joanne Davis United States	22	576 0.8×	261 0.6×	338 1.3×	220 1.1×	402 2.7×	35	1.7k

Countries citing papers authored by Katja Mitrunen

Since Specialization

Citations

This map shows the geographic impact of Katja Mitrunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Mitrunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Mitrunen more than expected).

Fields of papers citing papers by Katja Mitrunen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Mitrunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Mitrunen. The network helps show where Katja Mitrunen may publish in the future.

Co-authorship network of co-authors of Katja Mitrunen

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Mitrunen. A scholar is included among the top collaborators of Katja Mitrunen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Mitrunen. Katja Mitrunen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kataja, Vesa, Matti Eskelinen, Veli‐Matti Kosma, et al.. (2005). Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenetics and Genomics. 15(10). 749–752. 25 indexed citations

Hirvonen, Ari, Vesa Kataja, Matti Eskelinen, et al.. (2004). Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics. 14(4). 239–245. 46 indexed citations

Hirvonen, Ari, Vesa Kataja, Matti Eskelinen, et al.. (2004). NAT2 slow acetylator genotype as an important modifier of breast cancer risk. International Journal of Cancer. 114(4). 579–584. 47 indexed citations

Mitrunen, Katja & Ari Hirvonen. (2003). Molecular epidemiology of sporadic breast cancer. Mutation Research/Reviews in Mutation Research. 544(1). 9–41. 213 indexed citations

Mitrunen, Katja, Vesa Kataja, Matti Eskelinen, et al.. (2002). Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics. 12(1). 67–72. 57 indexed citations

Hirvonen, A., Christine Bouchardy, Katja Mitrunen, et al.. (2001). Polymorphic GSTs and cancer predisposition. Chemico-Biological Interactions. 133. 75–80. 8 indexed citations

Mitrunen, Katja. (2001). Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 22(5). 827–829. 207 indexed citations

Mitrunen, Katja, Vesa Kataja, Matti Eskelinen, et al.. (2001). Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.. PubMed. 10(3). 229–36. 153 indexed citations

Mitrunen, Katja, Vesa Kataja, Matti Eskelinen, et al.. (2001). Polymorphic catechol-O-methyltransferase gene and breast cancer risk.. PubMed. 10(6). 635–40. 76 indexed citations

10.

Benhamou, Simone, Christine Bouchardy, Anu Voho, et al.. (2001). Role of NAD(P)H:quinone oxidoreductase polymorphism at codon 187 in susceptibility to lung, laryngeal and oral/pharyngeal cancers. Biomarkers. 6(6). 440–447. 6 indexed citations

11.

Mitrunen, Katja, Vesa Kataja, Matti Eskelinen, et al.. (2000). Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.. PubMed. 9(12). 1343–8. 76 indexed citations

12.

Mitrunen, Katja, et al.. (2000). High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers.. PubMed. 60(3). 534–6. 75 indexed citations

13.

Wikman, Harriet, Christine Bouchardy, Katja Mitrunen, et al.. (1999). Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers.. PubMed. 9(4). 533–7. 28 indexed citations

14.

Bouchardy, Christine, Katja Mitrunen, Harriet Wikman, et al.. (1998). N-acetyltranferase NAT1 and NAT2 genotypes and lung cancer risk. Pharmacogenetics. 8(4). 291–298. 74 indexed citations

15.

Lövgren, Timo, Katja Mitrunen, Marjaana Mäkinen, et al.. (1996). One-step all-in-one dry reagent immunoassays with fluorescent europium chelate label and time-resolved fluorometry. Clinical Chemistry. 42(8). 1196–1201. 67 indexed citations

16.

Mitrunen, Katja, Kim Pettersson, Timo Piironen, et al.. (1995). Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clinical Chemistry. 41(8). 1115–1120. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact